Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sacubitril/valsartan versus enalapril for erectile dysfunction in men with HFrEF
2018-000220-33Phase 3Terminated
- Sponsor
- Novartis
- Start
- Nov 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in erectile dysfunction (ED) and heart failure with reduced ejection fraction (HFrEF) comparing Sacubitril/valsartan arm with Enalapril arm (2 arms). Primary endpoint: Erectile function score. Started Nov 2018; status: terminated.
02
Drugs
sacubitril + valsartanenalapril
03
Conditions
erectile dysfunction (ED)heart failure with reduced ejection fraction (HFrEF)
Beyond the preview
Go deeper on 2018-000220-33.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2018-000220-33.